
About Steerlife India Private Limited
Data last updated:
Steerlife India Private Limited was a private limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Steer Engineering Pvt Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 14 July 2015.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC081581. Its GSTIN is 29AAWCS0038F1Z2 (Karnataka).
The company had an authorised share capital of ₹6.1 Cr and a paid-up capital of ₹5.55 Cr. It was led by directors including Babu Padmanabhan (Managing Director) and Dipak Chattaraj.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at No. 290 4th Main 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.68 Cr, a decline of 70% compared to the previous year. For the same year it recorded a net loss of ₹9.42 Cr and EBITDA of -₹5.91 Cr (EBITDA margin -351.4%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 19% over five years.
The company had about 36 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: STEERLife. As per MCA filings, the company had open charges of ₹5 Cr and satisfied charges of ₹3.8 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.54 Cr; the latest was in October 2020. Its 4 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 2 smaller; the largest is St Johns Health Innovation Foundation with revenue of ₹1.74 Cr. The company has 10 MSME Form 1 returns on record between 2020 and 2024, listing 146 overdue payments to 35 micro and small suppliers.
The last known website on record is steerlife.com.
Company details
Contact details
Steerlife India Private Limited's registered office is in Bangalore, Karnataka. Its website is steerlife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 290 4th Main 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Steerlife India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Steerlife India operates one associated brand: STEERLife. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drugs and manufacturing equipment are developed by STEERLife. | steerlife.com |
Business activity
The main business activity of Steerlife India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Steerlife India Private Limited, buy the company report.
Financials of Steerlife India Private Limited
FY 2024 filings availableSteerlife India Private Limited reported revenue of ₹1.68 Cr (down 70% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 70% fall in the latest year. EBITDA fell 405% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -351.4% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Steerlife India Private Limited, buy the company report.
Board of directors of Steerlife India Private Limited
Steerlife India has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipak Chattaraj | Director | 27 Aug 2018 | 8 Years 2 Months | As last reported |
| Babu Padmanabhan Also directs: Geomater Private Limited, Phitons Bioengineering Private Limited, Sustainable Innovative Materials Private Limited and 2 more | Managing Director | 14 Jul 2015 | 11 Years 3 Months | As last reported |
| Himadri Sen Also directs: Omsav Pharma Research Private Limited | Director | 14 Jul 2015 | 11 Years 3 Months | As last reported |
| Indu Bhushan | Director | 21 Oct 2016 | 10 Years 0 Months | As last reported |
Peer comparison
Steerlife India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| St Johns Health Innovation Foundation | ₹1.74 Cr (FY 2025) | 24.0% | Bengaluru, Karnataka, India | |||
| Sirona Life Sciences Private Limited | ₹1.72 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India | |||
| Steerlife India Private Limitedthis company | ₹1.68 Cr (FY 2024) | -₹9.42 Cr | -70.0% | 36 | Bangalore, Karnataka, India | |
| Clinisyd Research Global Solutions Private Limited | ₹1.66 Cr (FY 2024) | 14.0% | Bangalore, Karnataka, India | |||
| Luxmatrainnovations Private Limited | ₹1.62 Cr (FY 2025) | 8.0% | Ernakulam, Kerala, India |
To see the full peer comparison of Steerlife India Private Limited, buy the company report.
Auditor
Steerlife India Private Limited is audited by Vasanth & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vasanth & Co. | FY 2023 | 008204S |
Shareholding
The shareholding of Steerlife India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Steerlife India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jun 2021 | 100463378 | Others | ₹1.25 Cr | Satisfied | |
| 23 Jun 2017 | 100108125 | Others | ₹2.55 Cr | Satisfied |
To see the full charge records of Steerlife India Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Steerlife India Private Limited has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.54 Cr; the latest was in October 2020.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Riverine Business Services Private Limited , IL&FS Investment Managers |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Dec 2019 | Funding round | ₹4.5 Cr | Investors: Prasthavana Advisory, Ledger Services Private Limited , 2 individuals |
| May 2017 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Steer Engineering Private Limited |
| Mar 2017 | Funding round | ₹4 Lakh | Investors: IL&FS Investment Managers, 3 individuals |
To see the full deal history of Steerlife India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Steerlife India Private Limited has 2 court cases on record: 2 filed by Steerlife India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Appeal | Filed by the company against an individual | Disposed |
| High Court of Karnataka | Court case (COP) | Filed by the company against an individual | Disposed |
To see the full case history of Steerlife India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Steerlife India Private Limited has 10 MSME Form 1 returns on record between 2020 and 2024, listing 146 overdue payments to 35 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 35)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Radiant Research Service Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Steerlife India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Steerlife India Private Limited has a workforce of 36 employees on its EPFO records as of May 14, 2024, across 1 active EPFO establishment.
GST
Steerlife India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAWCS0038F1Z2 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Steerlife India Private Limited, buy the company report.
Recent activity
Steerlife India Private Limited has 7 board changes on record since 2015: 4 appointments and 3 cessations. The latest: Babu Padmanabhan ceased to be Director on 01 Sep 2019.
2 earlier events are in the company report.
Frequently asked questions
Steerlife India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Steerlife India was a private limited company based in Bangalore, Karnataka, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 14 July 2015 and is registered under CIN U24230KA2015PTC081581. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Steerlife India was incorporated on 14 July 2015. It is registered with the Registrar of Companies, Bangalore.
Steerlife India had 4 directors:
- Babu Padmanabhan - Managing Director
- Dipak Chattaraj - Director
- Himadri Sen - Director
- Indu Bhushan - Director
The CIN (Corporate Identification Number) of Steerlife India is U24230KA2015PTC081581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Steerlife India is at No. 290 4th Main 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058.
Steerlife India can be reached through the website steerlife.com. Its registered office is in Bangalore, Karnataka, India.
The latest financial statements of Steerlife India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Steerlife India is 29AAWCS0038F1Z2, registered in Karnataka.
Steerlife India operated in the pharma industry, in the pharma contract r and d segment.
Steerlife India has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.54 Cr; the latest was in October 2020.
The peers of Steerlife India by revenue are St Johns Health Innovation Foundation, Sirona Life Sciences Private Limited, Clinisyd Research Global Solutions Private Limited, Luxmatrainnovations Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

